vs

Side-by-side financial comparison of Healthpeak Properties (DOC) and ITRON, INC. (ITRI). Click either name above to swap in a different company.

Healthpeak Properties is the larger business by last-quarter revenue ($719.4M vs $587.0M, roughly 1.2× ITRON, INC.). Healthpeak Properties runs the higher net margin — 73.2% vs 9.1%, a 64.0% gap on every dollar of revenue. On growth, Healthpeak Properties posted the faster year-over-year revenue change (3.1% vs -3.3%). Healthpeak Properties produced more free cash flow last quarter ($357.0M vs $79.0M). Over the past eight quarters, Healthpeak Properties's revenue compounded faster (8.9% CAGR vs -1.8%).

Healthpeak Properties, Inc. is an American real estate investment trust that invests in real estate related to the healthcare industry including senior housing, life science, and medical offices. It was organized in 2007 in Maryland and headquartered in Denver, Colorado with offices in Irvine, Nashville and San Francisco. As of December 31, 2019, the company owned interests in 617 properties.

Itron, Inc. is an American technology company that offers products and services for energy and water resource management. It is headquartered in Liberty Lake, Washington, United States. The company's products measure and analyze electricity, gas and water consumption. Its products include electricity, gas, water and thermal energy measurement devices and control technology, communications systems, software, as well as managed and consulting services.

DOC vs ITRI — Head-to-Head

Bigger by revenue
DOC
DOC
1.2× larger
DOC
$719.4M
$587.0M
ITRI
Growing faster (revenue YoY)
DOC
DOC
+6.4% gap
DOC
3.1%
-3.3%
ITRI
Higher net margin
DOC
DOC
64.0% more per $
DOC
73.2%
9.1%
ITRI
More free cash flow
DOC
DOC
$278.0M more FCF
DOC
$357.0M
$79.0M
ITRI
Faster 2-yr revenue CAGR
DOC
DOC
Annualised
DOC
8.9%
-1.8%
ITRI

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
DOC
DOC
ITRI
ITRI
Revenue
$719.4M
$587.0M
Net Profit
$114.0M
$53.6M
Gross Margin
40.3%
Operating Margin
17.4%
11.5%
Net Margin
73.2%
9.1%
Revenue YoY
3.1%
-3.3%
Net Profit YoY
2406.4%
-18.0%
EPS (diluted)
$0.16
$1.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DOC
DOC
ITRI
ITRI
Q1 26
$587.0M
Q4 25
$719.4M
$571.7M
Q3 25
$705.9M
$581.6M
Q2 25
$694.3M
$606.8M
Q1 25
$702.9M
$607.2M
Q4 24
$698.0M
$612.9M
Q3 24
$700.4M
$615.5M
Q2 24
$695.5M
$609.1M
Net Profit
DOC
DOC
ITRI
ITRI
Q1 26
$53.6M
Q4 25
$114.0M
$101.6M
Q3 25
$-117.1M
$65.6M
Q2 25
$31.7M
$68.3M
Q1 25
$42.8M
$65.5M
Q4 24
$4.5M
$58.1M
Q3 24
$85.9M
$78.0M
Q2 24
$146.0M
$51.3M
Gross Margin
DOC
DOC
ITRI
ITRI
Q1 26
40.3%
Q4 25
40.5%
Q3 25
58.6%
37.7%
Q2 25
60.2%
36.9%
Q1 25
61.1%
35.8%
Q4 24
60.3%
34.9%
Q3 24
60.0%
34.1%
Q2 24
60.6%
34.6%
Operating Margin
DOC
DOC
ITRI
ITRI
Q1 26
11.5%
Q4 25
17.4%
13.8%
Q3 25
9.2%
14.1%
Q2 25
5.7%
12.6%
Q1 25
7.7%
12.6%
Q4 24
-2.2%
10.2%
Q3 24
14.1%
12.0%
Q2 24
22.3%
10.6%
Net Margin
DOC
DOC
ITRI
ITRI
Q1 26
9.1%
Q4 25
73.2%
17.8%
Q3 25
-16.6%
11.3%
Q2 25
4.6%
11.3%
Q1 25
6.1%
10.8%
Q4 24
0.7%
9.5%
Q3 24
12.3%
12.7%
Q2 24
21.0%
8.4%
EPS (diluted)
DOC
DOC
ITRI
ITRI
Q1 26
$1.18
Q4 25
$0.16
$2.20
Q3 25
$-0.17
$1.41
Q2 25
$0.05
$1.47
Q1 25
$0.06
$1.42
Q4 24
$0.02
$1.26
Q3 24
$0.12
$1.70
Q2 24
$0.21
$1.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DOC
DOC
ITRI
ITRI
Cash + ST InvestmentsLiquidity on hand
$467.5M
$712.9M
Total DebtLower is stronger
$9.8B
Stockholders' EquityBook value
$7.5B
$1.6B
Total Assets
$20.3B
$4.0B
Debt / EquityLower = less leverage
1.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DOC
DOC
ITRI
ITRI
Q1 26
$712.9M
Q4 25
$467.5M
$1.0B
Q3 25
$91.0M
$1.3B
Q2 25
$89.4M
$1.2B
Q1 25
$70.6M
$1.1B
Q4 24
$119.8M
$1.1B
Q3 24
$180.4M
$982.5M
Q2 24
$106.9M
$920.6M
Total Debt
DOC
DOC
ITRI
ITRI
Q1 26
Q4 25
$9.8B
$1.3B
Q3 25
$9.1B
Q2 25
$9.0B
Q1 25
$8.9B
Q4 24
$8.7B
$1.3B
Q3 24
$8.6B
$1.3B
Q2 24
$8.6B
$1.3B
Stockholders' Equity
DOC
DOC
ITRI
ITRI
Q1 26
$1.6B
Q4 25
$7.5B
$1.7B
Q3 25
$7.6B
$1.7B
Q2 25
$7.9B
$1.6B
Q1 25
$8.2B
$1.5B
Q4 24
$8.4B
$1.4B
Q3 24
$8.6B
$1.3B
Q2 24
$8.8B
$1.2B
Total Assets
DOC
DOC
ITRI
ITRI
Q1 26
$4.0B
Q4 25
$20.3B
$3.7B
Q3 25
$19.6B
$3.7B
Q2 25
$19.8B
$3.6B
Q1 25
$19.8B
$3.5B
Q4 24
$19.9B
$3.4B
Q3 24
$20.0B
$3.4B
Q2 24
$20.2B
$3.3B
Debt / Equity
DOC
DOC
ITRI
ITRI
Q1 26
Q4 25
1.31×
0.74×
Q3 25
1.20×
Q2 25
1.14×
Q1 25
1.08×
Q4 24
1.04×
0.91×
Q3 24
1.00×
0.94×
Q2 24
0.98×
1.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DOC
DOC
ITRI
ITRI
Operating Cash FlowLast quarter
$1.3B
$85.5M
Free Cash FlowOCF − Capex
$357.0M
$79.0M
FCF MarginFCF / Revenue
49.6%
13.5%
Capex IntensityCapex / Revenue
124.4%
Cash ConversionOCF / Net Profit
10.99×
1.60×
TTM Free Cash FlowTrailing 4 quarters
$394.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DOC
DOC
ITRI
ITRI
Q1 26
$85.5M
Q4 25
$1.3B
$119.3M
Q3 25
$315.0M
$117.8M
Q2 25
$363.5M
$96.7M
Q1 25
$279.4M
$72.1M
Q4 24
$1.1B
$79.8M
Q3 24
$318.2M
$65.3M
Q2 24
$316.2M
$51.7M
Free Cash Flow
DOC
DOC
ITRI
ITRI
Q1 26
$79.0M
Q4 25
$357.0M
$111.5M
Q3 25
$113.4M
Q2 25
$90.7M
Q1 25
$67.5M
Q4 24
$333.7M
$70.2M
Q3 24
$58.7M
Q2 24
$44.6M
FCF Margin
DOC
DOC
ITRI
ITRI
Q1 26
13.5%
Q4 25
49.6%
19.5%
Q3 25
19.5%
Q2 25
14.9%
Q1 25
11.1%
Q4 24
47.8%
11.4%
Q3 24
9.5%
Q2 24
7.3%
Capex Intensity
DOC
DOC
ITRI
ITRI
Q1 26
Q4 25
124.4%
1.4%
Q3 25
0.8%
Q2 25
1.0%
Q1 25
0.8%
Q4 24
105.6%
1.6%
Q3 24
1.1%
Q2 24
1.2%
Cash Conversion
DOC
DOC
ITRI
ITRI
Q1 26
1.60×
Q4 25
10.99×
1.17×
Q3 25
1.80×
Q2 25
11.48×
1.41×
Q1 25
6.52×
1.10×
Q4 24
235.43×
1.37×
Q3 24
3.71×
0.84×
Q2 24
2.17×
1.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DOC
DOC

Segment breakdown not available.

ITRI
ITRI

Product revenues$477.8M81%
Service revenues$109.2M19%

Related Comparisons